comparemela.com

Latest Breaking News On - India resurgence fund - Page 11 : comparemela.com

IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores

IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

indiarf: IndiaRF kicks off talks for $1 bn fund - The Economic Times

India Resurgence Fund (IndiaRF), a special situations investment platform sponsored by Piramal Enterprises and Bain Capital Credit, is in talks with its limited partners (LPs) to raise its second fund targeting up to $1 billion. The first fund had a corpus of $629 million with main LPs including CPPIB and IFC. The second fund aims to attract commitments from CPPIB and IFC, with a first closing expected by December.

Piramal Alternatives invests $27 mn in specialty chemicals firm

Piramal group’s alternate asset arm Piramal Alternatives has tapped the fragrance and flavour (F&F) sector making an investment of Rs 225 crore (nearly $27 million) in ..

Piramal: India s Piramal plans to raise $1 5bn for private credit

Piramal Alternatives plans to raise $1.5 billion for investment in Indias high-yield companies via private credit, according to its chief executive officer. The unit of Piramal Group, which is controlled by billionaire Ajay Piramal, has four existing private credit funds that together have raised $4 billion, said Kalpesh Kikani, managing director and chief executive officer at Piramal Alternatives.

api: India resurgence fund in talks to acquire Ind-Swift s API business

api: India resurgence fund in talks to acquire Ind-Swift s API business
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.